Literature DB >> 9094994

Multinucleated cells in pigmented villonodular synovitis and giant cell tumor of tendon sheath express features of osteoclasts.

J M Darling1, S R Goldring, Y Harada, M L Handel, J Glowacki, E M Gravallese.   

Abstract

Pigmented villonodular synovitis (PVNS) and the histologically related lesion giant cell tumor of tendon sheath (GCTTS) are idiopathic, proliferative lesions that can induce osteolysis and formation of bone cysts. These lesions contain two predominant cell types: mononuclear polyhedral cells and multinucleated cells (MNCs). Previous studies demonstrated that the mononuclear cells exhibit phenotypic features consistent with derivation from a monocyte/macrophage lineage. The cell lineage of the MNCs and their relationship to osteoclasts are not known. To characterize the MNCs in these lesions and to establish the relationship of these MNCs to osteoclasts, histological sections from six cases of PVNS and two cases of GCTTS were studied. Mononuclear cells expressed CD14 and HLA-DR, in keeping with their relationship to cells of the monocyte/macrophage lineage. Characterization of the MNCs revealed features associated with an osteoclast phenotype. Seven of the eight specimens contained MNCs that were intensely tartrate-resistant acid phosphatase positive; approximately 5% of the mononuclear cells were tartrate-resistant acid phosphatase positive, and these tended to surround MNCs. MNCs in both lesions reacted strongly with the 23C6 monoclonal antibody that recognizes the alpha V beta 3 integrin (the vitronectin receptor), as did several mononuclear cells surrounding the MNCs. Most MNCs did not express CD14 or HLA-DR. Expression of receptors for calcitonin, a marker for osteoclasts, was detected on MNCs after incubation of sections with 125I-labeled salmon calcitonin and emulsion autoradiography. MNCs in four of six PVNS and two of two GCTTS samples demonstrated specific calcitonin binding. Expression of mRNA for calcitonin receptor was confirmed in all cases by reverse transcriptase polymerase chain reaction. These results demonstrate that MNCs in PVNS and GCTTS express phenotypic features of authentic osteoclasts and suggest that osteoclast-like multinucleated cells can arise in synovial soft tissues remote from bone.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9094994      PMCID: PMC1858182     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  47 in total

1.  Giant cell tumour associated with rheumatoid arthritis.

Authors:  A Reginato; V Martinez; H R Schumacher; J Torres
Journal:  Ann Rheum Dis       Date:  1974-07       Impact factor: 19.103

2.  Pigmented villonodular synovitis: light and electron microscopic studies.

Authors:  H R Schumacher; P Lotke; B Athreya; S Rothfuss
Journal:  Semin Arthritis Rheum       Date:  1982-08       Impact factor: 5.532

3.  Pigmented villonodular synovitis and tenosynovitis: a clinical epidemiologic study of 166 cases and literature review.

Authors:  B W Myers; A T Masi
Journal:  Medicine (Baltimore)       Date:  1980-05       Impact factor: 1.889

Review 4.  Characterization of cells from human giant cell tumors of bone.

Authors:  S R Goldring; A L Schiller; H J Mankin; J M Dayer; S M Krane
Journal:  Clin Orthop Relat Res       Date:  1986-03       Impact factor: 4.176

5.  Monoclonal antibodies to osteoclastomas (giant cell bone tumors): definition of osteoclast-specific cellular antigens.

Authors:  M A Horton; D Lewis; K McNulty; J A Pringle; T J Chambers
Journal:  Cancer Res       Date:  1985-11       Impact factor: 12.701

6.  Lysozyme and alpha 1-antitrypsin in giant-cell tumor of bone and in other lesions that contain giant cells.

Authors:  L Ling; M J Klein; H A Sissons; G C Steiner
Journal:  Arch Pathol Lab Med       Date:  1986-08       Impact factor: 5.534

7.  Demonstration of tartrate-resistant acid phosphatase in un-decalcified, glycolmethacrylate-embedded mouse bone: a possible marker for (pre)osteoclast identification.

Authors:  F P van de Wijngaert; E H Burger
Journal:  J Histochem Cytochem       Date:  1986-10       Impact factor: 2.479

8.  Pigmented villonodular synovitis of synovial joints: clinical, pathologic, and radiologic features.

Authors:  R H Dorwart; H K Genant; W H Johnston; J M Morris
Journal:  AJR Am J Roentgenol       Date:  1984-10       Impact factor: 3.959

9.  Giant cell tumor of tendon sheath and pigmented villonodular synovitis: an ultrastructural study.

Authors:  A Alguacil-Garcia; K K Unni; J R Goellner
Journal:  Am J Clin Pathol       Date:  1978-01       Impact factor: 2.493

Review 10.  Anaplastic carcinoma of the thyroid with osteoclast-like giant cells.

Authors:  J H Esmaili; G R Hafez; T F Warner
Journal:  Cancer       Date:  1983-12-01       Impact factor: 6.860

View more
  14 in total

1.  Stimulation of osteoclast formation by inflammatory synovial fluid.

Authors:  Iannis E Adamopoulos; Lynett Danks; Ichiro Itonaga; Rachel M Locklin; Afsie Sabokbar; David J P Ferguson; Nicholas A Athanasou
Journal:  Virchows Arch       Date:  2006-04-21       Impact factor: 4.064

2.  Expression of PD-L1 in mononuclear cells, multinucleated cells, and foam cells in tenosynovial giant cell tumors.

Authors:  Biqiang Zheng; Lin Yu; Jingying Hu; Huili Xu; Jian Wang; Yingqiang Shi; Xiaoying Luo; Wangjun Yan
Journal:  Int J Clin Exp Pathol       Date:  2019-03-01

Review 3.  Locally Aggressive Connective Tissue Tumors.

Authors:  Mrinal M Gounder; David M Thomas; William D Tap
Journal:  J Clin Oncol       Date:  2017-12-08       Impact factor: 44.544

4.  Diffuse-type giant cell tumor of the tendon sheath in the temporal region incidentally diagnosed due to a temporal tumor: A report of two cases and review of the literature.

Authors:  Jia Ruo Qin; Long Jin; Kong Liang Li; Shan Shan Zhang; Jie Kong; Hong Yu Yang
Journal:  Oncol Lett       Date:  2015-05-28       Impact factor: 2.967

5.  Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis.

Authors:  E M Gravallese; Y Harada; J T Wang; A H Gorn; T S Thornhill; S R Goldring
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

6.  Increased expression of humanin peptide in diffuse-type pigmented villonodular synovitis: implication of its mitochondrial abnormality.

Authors:  K Ijiri; H Tsuruga; H Sakakima; K Tomita; N Taniguchi; K Shimoonoda; S Komiya; M B Goldring; H J Majima; T Matsuyama
Journal:  Ann Rheum Dis       Date:  2004-11-26       Impact factor: 19.103

7.  Pigmented villonodular synovitis great toe.

Authors:  Ajay Lunawat; Dharmendra Mehta; Sanjay Datey; N Charles; S Khandelwal; B Shaam; J K Yadav
Journal:  Indian J Surg       Date:  2012-07-31       Impact factor: 0.656

8.  Cytokine and matrix metalloproteinase expression in pigmented villonodular synovitis may mediate bone and cartilage destruction.

Authors:  R J O'Keefe; R N Rosier; L A Teot; J M Stewart; D G Hicks
Journal:  Iowa Orthop J       Date:  1998

9.  Persistent expression of mitogenic/transforming factors at the site of failed orthopaedic implants: the impact on immune reactivity.

Authors:  J Bainbridge; N Al-Saffar
Journal:  J Mater Sci Mater Med       Date:  1998-12       Impact factor: 3.896

10.  Tenosynovial giant cell tumour (pigmented villonodular synovitis-)-like changes in periprosthetic interface membranes.

Authors:  Stephan Söder; Stefan Sesselmann; Thomas Aigner; Stephan Oehler; Abbas Agaimy
Journal:  Virchows Arch       Date:  2015-11-09       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.